NxStage posts record-breaking Q3 results, shares gain 13%

NxStage boasts another solid quarter with a nearly double-digit increase in sales and halved 3rd quarter losses, gaining a 13% boost on Wall Street.

NxStage Medical [1] (NSDQ:NXTM [2]) posted yet another record-breaking quarter, cutting losses in half and reporting strong growth in sales.

The Lawrence, Mass.-based medical device maker posted $2.6 million in net losses, or 4¢ per share, on sales of $61.2 million for the 3 months ended Sept. 30. That compared with a net loss of $5.3 million, or 10¢ per share, on sales of $55.9 million during the same period last year.